Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/30342
Title: | Antiplatelet drugs, anticoagulants and elective surgery. | Authors: | Tran H. ;Merriman E. | Institution: | (Merriman) Monash Medical Centre, Australia (Tran) Monash Medical Centre, The Alfred Hospital, Australian Centre for Blood Diseases, Monash University, Australia | Issue Date: | 8-Oct-2012 | Copyright year: | 2011 | Publisher: | National Prescribing Service (3/2 Phipps Close, Deakin ACT 2602, Australia) | Place of publication: | Australia | Publication information: | Australian Prescriber. 34 (5) (pp 139-143), 2011. Date of Publication: October 2011. | Abstract: | There is an increased risk of bleeding when patients taking anticoagulant or antiplatelet drugs require surgery. This risk must be balanced against the risk of harm if treatment is stopped. For many minor procedures aspirin or warfarin can be continued. Patients having non-cardiac surgery may be able to continue aspirin, but clopidogrel should be stopped unless there is a high risk of thrombosis. Patients taking warfarin may require bridging anticoagulation around the time of major surgery. This involves replacing the warfarin with unfractionated or low molecular weight heparin. Consultation with a cardiologist is particularly recommended if a patient with a coronary stent requires surgery. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.18773/austprescr.2011.074 | ISSN: | 0312-8008 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/30342 | Type: | Article |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.